The Postoperative Radiotherapy in N1 Breast Cancer Patients

This study is a multicenter, randomized, phase 3 clinical trial in patients with breast cancer, randomizing radiotherapy group (postmastectomy radiation therapy (PMRT)/whole breast irradiation plus regional radiotherapy (WBI+regional RT) versus and no PMRT/WBI alone group. This is a non-inferiority study aiming that there is no significant difference in the 7-year disease-free survival rate between the two groups.

Trial Details

NCT ID
NCT05440149
Phase
PHASE3
Sponsor
Seoul National University Hospital
Status
RECRUITING
Cancer Type
Breast Cancer
Locations (sample)
  • Seoul, Jongro-gu, South Korea

Key Eligibility Criteria

  • Patients aged 19 years or older.
  • A female patient who underwent breast-conserving surgery or mastectomy for invasive breast cancer.
  • Patient with stage pN1 after surgery on histopathologic examination.
  • However, if mastectomy was performed, 5 or more nodes should be resected in the case of 1 positive node, and axillary lymph node dissection (ALND) …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →